Webster Bank’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Webster Bank’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$132K	Hold	1,670	–	–	0.01%	272
2025 Q4	$137K	Hold	1,670	–	–	0.01%	253
2025 Q3	$117K	Hold	1,670	–	–	0.01%	269
2025 Q2	$107K	Hold	1,670	–	–	0.01%	275
2025 Q1	$106K	Hold	1,670	–	–	0.01%	271
2024 Q4	$111K	Hold	1,670	–	–	0.01%	273
2024 Q3	$117K	Hold	1,670	–	–	0.01%	271
2024 Q2	$108K	Sell	1,670 -155	-8%	-$9.81K	0.01%	264
2024 Q1	$118K	Sell	1,825 -1,470	-45%	-$95.7K	0.01%	255
2023 Q4	$217K	Hold	3,295	–	–	0.03%	201
2023 Q3	$188K	Hold	3,295	–	–	0.03%	201
2023 Q2	$202K	Hold	3,295	–	–	0.03%	197
2023 Q1	$207K	Hold	3,295	–	–	0.03%	203
2022 Q4	$209K	Hold	3,295	–	–	0.03%	203
2022 Q3	$194K	Hold	3,295	–	–	0.03%	199
2022 Q2	$190K	Hold	3,295	–	–	0.03%	195
2022 Q1	$204K	Hold	3,295	–	–	0.02%	197
2021 Q4	$235K	Hold	3,295	–	–	0.02%	200
2021 Q3	$247K	Hold	3,295	–	–	0.03%	185
2021 Q2	$255K	Hold	3,295	–	–	0.03%	185
2021 Q1	$243K	Hold	3,295	–	–	0.03%	194
2020 Q4	$231K	Hold	3,295	–	–	0.03%	194
2020 Q3	$187K	Hold	3,295	–	–	0.02%	203
2020 Q2	$192K	Hold	3,295	–	–	0.03%	190
2020 Q1	$153K	Hold	3,295	–	–	0.03%	191
2019 Q4	$184K	Sell	3,295 -200	-6%	-$10.4K	0.02%	208
2019 Q3	$166K	Hold	3,495	–	–	0.02%	216
2019 Q2	$187K	Hold	3,495	–	–	0.03%	204
2019 Q1	$193K	Sell	3,495 -580	-14%	-$30.7K	0.03%	197
2018 Q4	$192K	Hold	4,075	–	–	0.03%	188
2018 Q3	$242K	Buy	+4,075	New	+$238K	0.03%	190
2018 Q2	–	Sell	-5,250	Closed	-$258K	–	515
2018 Q1	$258K	Sell	5,250 -128	-2%	-$6.53K	0.04%	182
2017 Q4	$254K	Hold	5,378	–	–	0.03%	189
2017 Q3	$269K	Hold	5,378	–	–	0.04%	190
2017 Q2	$246K	Sell	5,378 -345	-6%	-$14.9K	0.04%	192
2017 Q1	$242K	Sell	5,723 -397	-6%	-$16.6K	0.04%	197
2016 Q4	$238K	Sell	6,120 -930	-13%	-$37.5K	0.03%	196
2016 Q3	$296K	Hold	7,050	–	–	0.04%	177
2016 Q2	$261K	Sell	7,050 -337	-5%	-$13.2K	0.04%	188
2016 Q1	$283K	Sell	7,387 -350	-5%	-$13.6K	0.04%	178
2015 Q4	$391K	Sell	7,737 -438	-5%	-$21.6K	0.06%	152
2015 Q3	$373K	Sell	8,175 -4,575	-36%	-$256K	0.07%	146
2015 Q2	$744K	Sell	12,750 -790	-6%	-$45.2K	0.12%	119
2015 Q1	$746K	Sell	13,540 -325	-2%	-$17.6K	0.12%	116
2014 Q4	$696K	Sell	13,865 -375	-3%	-$18.4K	0.12%	120
2014 Q3	$658K	Sell	14,240 -975	-6%	-$43.9K	0.12%	118
2014 Q2	$665K	Sell	15,215 -29,600	-66%	-$1.2M	0.11%	115
2014 Q1	$1.87M	Sell	44,815 -885	-2%	-$37.9K	0.26%	79
2013 Q4	$1.69M	Sell	45,700 -500	-1%	-$17.9K	0.24%	83
2013 Q3	$1.62M	Sell	46,200 -1,300	-3%	-$43.1K	0.25%	84
2013 Q2	$1.37M	Buy	+47,500	New	+$1.35M	0.17%	107

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Webster Bank's PBE Position: Q1 2026 in Review

Webster Bank held its Invesco Biotechnology & Genome ETF (PBE) position steady in Q1 2026 at 1,670 shares worth $132K. The position accounts for 0.01% of the portfolio, ranked #272.

Webster Bank first reported a position in PBE in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.87M in Q1 2014. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

Webster Bank held 1,670 shares of Invesco Biotechnology & Genome ETF worth $132K as of Q1 2026.
Webster Bank left its Invesco Biotechnology & Genome ETF share count unchanged in Q1 2026.
Invesco Biotechnology & Genome ETF made up 0.01% of Webster Bank's portfolio in Q1 2026, its #272 holding.
Webster Bank first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and has held it in 51 quarters since.
Webster Bank's Invesco Biotechnology & Genome ETF position peaked at $1.87M in Q1 2014.
100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on Webster Bank's 13F filing for Q1 2026, filed 17 Apr 2026.